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Introduction
Aging of population is an important social,
economic and political issue. It has been estimated
that in 2030, approximately 21% of the population
will be aged over 65 years; thus will further
increase the number of geriatric patients and health
demand(1). 
In elderly, Gastro-Esophageal Reflux Disease
(GERD) is very common among gastrointestinal
diseases, unusually more severe than young patients
frameworks, and frequently under-diagnosed
because of the chronic PPI therapy prescribed as
protection for iatrogenic drug damages, such as
antiplatelet and NSAIDs(2,3). 
GERD is a consequence of pathological reflux of
gastric and/or duodenal contents in the esophagus,
which can induce a spectrum of clinical conditions,
ranging from simple symptomatic reflux to esophageal
mucosal injury (esophagitis) and even complications,
such as stenosis and Barrett’s esophagus(4-6). 
The study of the different GERD framework in
elderly is complicated by several factors.
Esophageal sensitivity seems to decrease with aging
and elderly patients usually underestimate and toler-
ate symptoms that the younger ones do not. The
coexistence of other diseases, such as chronic
obstructive pulmonary disease and coronary heart
disease, may be confused or exacerbated by
GERD(7). 
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Furthermore, a long-term therapy with drugs,
such as calcium-antagonists and nitrates, facilitates
the GERD onset, reducing lower esophageal
sphincter (LES) muscle tone and consequently
determining incontinence. Cholecystectomy is
another possible risk factor for a constant duodenal-
gastric reflux, which can easily spread to the esoph-
agus. Generally, in elderly, most common symp-
toms are regurgitation, dysphagia, chest pain and
respiratory symptoms rather than heartburn(8). 
Here we reported a retrospective study of our
endoscopic series in order to assess the prevalence
and clinical characteristics of GERD in the elderly.
Materials and methods
We conducted a retrospective study of patients
(both outpatient and inpatients), who underwent
EGD, from January 2001 to December 2010, at our
Gastroenterology and Digestive Endoscopy
Service, inside the  Department of Geriatrics of
University Hospital of Palermo. 
The study population was divided into two
groups, respectively aged <65 years old (GROUP
A) and ≥ 65 years old (GROUP B), who com-
plained about symptoms referable to the upper gas-
trointestinal tract (heartburn, chest pain, dysphagia,
regurgitation, and dyspepsia) and/or anemia of
unknown origin. The endoscopic diagnosis of
esophagitis was made according to Los Angeles
classification. It was also evaluated the pharmaco-
logical therapy assigned to included patients, both
in acute and maintenance phase: antacids were
excluded from the evaluation, as often self-pre-
scribed and not objectively quantifiable.
The study was conducted in accordance with
the principles of the Declaration of Helsinki (World
Medical Association Declaration of Helsinki 1989)
and Good Clinical Practice (European Agency for
the Evaluation of Medicinal Products 2002). The
Ethics Committee of the University Hospital of
Palermo approved the study and all patients gave
their informed consent to participate.
Results
In the study period, 11.758 outpatient and
inpatient visits were carried out, followed by 9457
EGDs. Considering exclusively the subjects who
underwent EGD, the patients (M/F) ratio was 1.7
(5968 males vs. 3489 females), aged between 12
and 94 years old (mean age 50.8 ± 16.4 years old).
Of these patients, 6308 were  aged <65 years old
with M/F ratio 2.66 (4583 males vs. 1725 females)
and 3149 were aged ≥ 65 years old with M/F ratio
2.67 (2292 males vs. 857 females). 
The number of patients subjected to EGD with
GERD-related symptoms and/or signs were 3663
(almost one third of the total), of whom 2594 aged
<65 years old (GROUP A), with M/F ratio 1.73
(1645 males vs. 949 females), and 1069 aged ≥ 65
years old (GROUP B), with M/F ratio 1.34 (613
males vs. 456 females). 
Esophagitis diagnosis was made on 2549
patients, while 1114 did not have esophageal injury,
only reporting symptoms. Among the patients with
esophagitis, 1815 were aged <65 years old with
M/F ratio 1.55 (1103 males vs. 712 females) and
734 aged ≥ 65 years old M/F ratio 1.58 (450 males
vs. 284 females). 
Figure 1 shows the frequency of esophagitis
and its different degrees in the 3663 patients
underwent EGD with GERD-related
symptoms/sings. In GROUP A, GERD symp-
toms/signs in absence of injury were found more
frequently (41% vs. 29%), while esophagitis
severe grade (III-V) were rarely observed (6% vs.
11%), compared to the GROUP B. 
Figure 1: esophagitis frequency.
Figure 2: association of esophagitis with
hiatal hernia, gastric ulcer and duodenal
ulcer.
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It was also evaluated the association with
hiatal hernia and gastric and/or duodenal ulcer
(Figure 2). The hiatal hernia was more common in
GROUP B (45% vs. 74%), as well as duodenal
ulcer (4% vs. 20%). 
As regards symptoms (Figure 3) elderly
showed more frequently dysphagia (2% vs. 6%),
dyspepsia (7% vs. 14%) and anemia (1% vs. 6%)
compared to GROUP A, while among the younger
patients regurgitation (33% vs. 24%) and chest pain
(16% vs. 11%) were more frequent compared to
GROUP B. Heartburn had a frequency similar
between the two groups (39% vs. 40%). 
An acute therapy was carried out by 2439
patients (96% of the 2549 patients with esophagi-
tis), it was differentiated in relation to the mole-
cules used (cisapride, H2-receptor antagonists,
PPIs, and drugs association) and the results were
comparable to those referred in the current litera-
ture, as shown in Figure 4. The long-term treatment
(3-48 months), followed by 1507 patients (59% of
the 2549 patients with esophagitis) is shown in
Figure 5, also comparable with the results currently
available in the literature. Non significant differ-
ences where found between elderly and younger
patients as regards healing and remission rates (data
not shown).
Discussion
In our series, comparing elderly and younger
patients, with GERD-related symptoms/sings,
underwent EGD, severe esophagitis was found
more frequently in the elderly, as well as the associ-
ation with other gastroduodenal diseases, such as
hiatal hernia or duodenal ulcer. Comparison of
GERD-related symptoms/signs between the groups
showed that dysphagia, dyspepsia and anemia were
more represented in the elderly, while in the
younger group regurgitation and chest pain had a
higher frequency; heartburn had a similar rate in
both groups. As regards the effectiveness of acute
therapy and long-term treatment, PPIs showed the
highest rates of healing and remission of symptoms,
respectively, in both groups, without significant dif-
ferences. 
General population complains of monthly
heartburn between 21% and 36%, and between 5%
and 7% of daily one. In a recent study, performed
on 559 elderly patients, symptoms were reported at
least once a month in 54% of men and 66% of
women, while 8% of males and 15% of females had
symptoms suggestive of gastro-esophageal reflux at
least once a week. In addition to reflux typical
symptoms, chest pain, dyspepsia, and respiratory
symptoms were associated too (6). 
Another study showed that 32-43% of patients
with GERD did not present endoscopic lesions,
while 50-60% of patients with typical symptoms
and 60% of patients with atypical symptoms had an
endoscopic diagnosis of esophagitis. Respiratory
symptoms were reported in 57% of patients with
esophagitis compared with 33% of those without
this last one(9). 
Moreover, in elderly, is frequent the finding of
hiatal hernia, a GERD closely related condition. As
Figure 3: symptoms/signs frequency.
Figure 4: GERD short-term therapy expres-
sed as healing rate. 
Figure 5: GERD long-term therapy expres-
sed as remission rate.
well as GERD prevalence increases with age,
becoming particularly high after 50 years old, so
the incidence increases significantly (mean age 55
years old). Even esophagitis severity increases sig-
nificantly with aging, as reported in an endoscopic
study in which 75% of patients with esophagitis
was represented by “sixties”. In this regard, a recent
US study has confirmed this trend showing an
increase in hospital admissions for esophagitis,
esophageal ulcer and stenosis(8). 
GERD complications are more common
among the elderly. In particular, esophageal steno-
sis and Barrett’s esophagus reach their maximum
frequency between 50 and 70 years old. Prevalence
of esophageal stenosis in patients with esophagitis
ranges between 10% and 20%, while incidence is
estimated around 8%. Barrett’s esophagus, charac-
terized by the presence of columnar epithelium
replacing normal squamous epithelium in the third
lower esophageal, is considered a pre-neoplastic
lesion, which neoplastic transformation risk is from
30 to 125 times higher than the normal epithelium;
adenocarcinoma onset within a Barrett’s esophagus
has a prevalence ranging between 8% and 15%,
with an average age around 60 years old(5,10).
However, reduction or disappearance of symp-
toms does not always coincide with reflux disease
disappearance: patients tested 17-32 years after
diagnosis, treated with medical therapy, have shown
that, though 75% had symptoms improvement,
about 66% showed pathological reflux signs (pH-
metry positive, esophagitis, and Barrett's esopha-
gus)(11,12). Most of the patients with a durable remis-
sion, changed lifestyle, took antacids as needed, but
most of all cycles of 4-8 weeks with anti-secretory
drugs, while in others was necessary a continuous
control by means of medication and in rare cases,
non-responders to therapy with high proton pump
inhibitors (PPIs) dose, an anti-reflux surgery(13). 
In elderly patients, endoscopy must be consid-
ered a first-level exam, especially if there are alarm
symptoms (e.g. weight loss, dysphagia, anemia,
etc.). EGD execution is necessary because sympto-
matology is often poorly represented and neoplastic
diseases of esophagus and/or of gastric fundus,
which initially may provoke symptoms similar to
those of GERD, must be excluded(14-16). 
Monitoring esophageal pH can be useful for
GERD diagnosis and therapy, in particular for non-
esophageal manifestations and non-cardiac chest
pain. Is a valid method, fairly widespread, to quan-
tify esophageal acid exposure. Calculate the per-
centage of total time spent below pH values of 4.0
in 24 hours (optimal discriminant value) and the
association with symptoms is essential to evaluate
atypical or sporadic disorders(17,18). 
Gastric scintigraphy has become the gold stan-
dard for the study of gastric emptying, however it is
not quite common or standardized. The lack of stan-
dardization and the probable heterogeneity of popu-
lations studied, justify the different results reported
by literature, although the majority of studies seems
to show a slow emptying in the elderly(9).
Treatment goals are, in the attack phase,
symptoms resolution and healing of injuries result-
ing from changes in lifestyle, not always effective
and practicable, and from drug therapy. Another
objective is to consolidate the results obtained
maintaining remission of symptoms, healing of
injuries, and also preventing the complications(19). 
Antacids and mucous-protectors, such as
sucralfate and alginic acid, are usually taken as self-
medication. In literature, there are some compara-
tive studies between alginate-antacids and placebo,
which show a limited role in controlling symptoms
for alginic acid(2,3,20). 
H2-antagonists in the elderly may cause vari-
ous dose-dependent side effects. The most impor-
tant is central nervous system involvement with a
variety of symptoms, including: delirium, confu-
sion, hallucinations, depression, decreased libido
and Parkinsonism. The incidence of these effects
increases particularly in patients with renal failure,
so these medicaments should be abandoned(2,3). 
The first PPI introduced in clinical practice
was omeprazole, to which was subsequently added
lansoprazole and pantoprazole, molecules with a
faster activation, with a greater selectivity for the
acid compartment of the gastric parietal cell and,
above all, with a less interaction with the hepatic
oxidative enzyme systems, connected to
cytochrome P450, which make them more manage-
able, and secure specially in elderly patients or in
those with decreased hepatic and renal function,
without adjusting the dose and, above all, with a
lower risk of drug interactions(21). The last molecule
of PPIs group, esomeprazole, isomeric omeprazole
derivative, showed a more powerful anti-secretory
action with daily doses of 40 mg, which produced a
significant benefit in the treatment of erosive
esophagitis and in pain chest, with healing rates
slightly higher than with other PPIs(2,22). 
Prokinetics most frequently used are domperi-
done (anti-dopaminergic action), metoclopramide
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(central dopaminergic antagonist), and levosulpiri-
de, which due to the several side effects has limited
use(23). 
GERD natural history shows that up to 80% of
patients have a relapse after acute healing, usually
within six months from treatment interruption. This
determines the need for a long-term therapy(23).
Surgery is a viable option if symptomatology
interferes significantly on the patient quality of life,
if the latter refuses a long term medical therapy, and
in case of complicated disease (severe esophagitis
and/or stenosis). Nevertheless, indications for
surgery are generally limited to young patients with
a life expectancy of many years, in which surgical
therapy may be an effective alternative to medical
one. Recent introduction of laparoscopic surgery in
GERD treatment expanded the number of subjects
eligible for Nissen fundoplication intervention. The
short-medium term clinical results are comparable
to those produced by traditional surgery. A study
carried out on 359 patients aged> 65 years showed,
after the intervention, a similar symptoms improve-
ment to that found among younger patients, an
equivalent morbidity and length of hospitalization,
emphasizing that the choice of surgical treatment is
no longer limited by age. However, it must be con-
sidered that elderly patients have a higher surgical
risk than younger ones(2,24). 
Medical and surgical therapy are undoubtedly
two cornerstones of GERD treatment, but to date
endoscopy offers new possibilities(25). Three differ-
ent approaches are available today:
1) endoscopic “sewing machine”, by which
could be performed sutures within the cardia creat-
ing mucosal folds to contrast reflux(26);
2) Radio-Frequency (NARROW procedures),
producing focal lesion in the cardia muscle layer,
that hesitate in fibrosis with reflux reduction(27);
3) injection of inert substances (polymers) into
the esophageal-gastric junction determining the cre-
ation of an anti-reflux barrier(28). These procedures
seem very promising but unfortunately are just in
an experimental stage. Before being widely adopted
will be necessary to make more accurate studies
and a better standardization of procedures. 
Conclusions
In conclusion, GERD is a common condition
in the elderly, which often develops itself in an
atypical way, with more frequent and severe com-
plications. As regards the pathophysiological mech-
anisms in elderly patients compared to younger
ones, it seems to have a specific role factors such as
use of drugs that reduce the LES tone or have direct
detrimental action on the esophageal mucosa (in
this regard a special note, in women, the use of
osteoporosis medications, especially bisphospho-
nates, for the well-known esophageal lesions that
can cause), hiatal hernia, probably duodenal-gastric
reflux, presence of comorbidities (overweight,
being bedridden, diabetes mellitus and neurological
disorders). In this context, the progressive age-
related decrease of hydrochloric acid secretion does
not seem to have an important protective role.
Diagnostic and therapeutic approach must consider
the psychological and physical changes often pre-
sent in the elderly. In absolute terms, treatment
effectiveness is very similar between young and
elderly. PPIs in the elderly, as in the young, are con-
sidered the most effective molecules on symptoms
and lesions of all grades. The choice of a specific
molecule between PPIs has no influence in the
young, while in the elderly is required, accounting
comorbidities and polypharmacy (drug interac-
tions). Our results confirm literature data.
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